Bone morphogenetic proteins (BMPs) are potent bone-forming agents that show
clinical efficacy when used in patients to augment fracture-healing. Molecular
profiling of fracture tissues has confirmed that BMPs 2, 3, 4, 5, 6, and 7 are
expressed during the healing process, and it has identified a specific
temporal pattern of expression for each BMP. Mice engineered to express
increased levels of BMP antagonists have fragile bones that are prone to
fracture, suggesting that BMPs not only mediate bone formation in the context
of repair, but may also have a role in maintaining adult bone. In this study,
mice carrying floxed Bmp4 alleles were bred with
Prx1-cre transgenic mice to establish limb-specific removal
of Bmp4. We compared these mice to mice in which Bmp2 was
specifically deleted from the limb, and we then assessed limb skeletogenesis
and fracture-healing. Limb skeletogenesis occurs normally in the absence of
BMP4, and postnatal skeletal growth was also unaffected when BMP4 was removed.
When mice lacking BMP4 were challenged to repair fractures, they were able to
mount a successful healing response. We concluded that BMP4 is not required
for formation of the limb skeleton and that femur fracture-healing is
unaffected by the absence of BMP4. This study demonstrates that BMP4 is not
required for bone formation and function in the limb, giving us further
insights into the utility of recombinant human BMPs as therapeutic agents.